Medacta Group SA reports strong revenue growth at 21.4% at constant currency and adjusted EBITDA margin at 28.2% in the first semester 2023

Medacta Group SA / Key word(s): Half Year Results/Half Year Results Medacta Group SA reports strong revenue growth at 21.4% at constant currency and adjusted EBITDA margin at 28.2% in the first semester 2023 22-Sep-2023 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Press Release – Ad-hoc announcement pursuant to Art. 53 LR

Medacta Group SA reports strong revenue growth at 21.4% at constant currency¹ and adjusted EBITDA¹ margin at 28.2% in the first semester 2023

• 1H 2023 revenue increased to Euro 255.1 million, or 21.4% c.c.¹ (20.8% reported) from 1H 2022;
• Adjusted EBITDA grew to Euro 71.9 million, corresponding to 28.2% margin, including a headwind from negative FX translation effect of 1.6%;
• Continued focus on Medical Education and Salesforce expansion in all business lines and geographies;
• Robust supply chain able to support an accelerated growth;
• Outlook FY 2023: revenue growth in c.c. expected in the range of 15% to 18% and adjusted EBITDA in c.c. is predicted to remain largely in line with 2022, in the absence of unforeseen events.

 CASTEL SAN PIETRO, 22 September 2023 – Medacta Group SA (“Medacta”, SIX:MOVE) today reported financial results for the Half-Year ending 30 June, 2023.

Francesco Siccardi, CEO of Medacta, commented: “We are proud to report a strong organic growth thanks to a good product differentiation, an effective marketing strategy and a constant expansion of our market opportunities. Margins increased notwithstanding the investments in structures needed to sustain our fast expansion. This remarkable performance proves the effectiveness of our strategy and provides confidence in our ability to execute the long-term value creation.”

 Our Achievements 

We remain dedicated to improve patient outcomes through innovative minimal invasive techniques and personalized solutions, maintaining at the same time a strong focus on healthcare sustainability.